Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

Share Price is delayed by 15 minutes
Get Live Data
174.00    0.00 (0.00%)
Bid:
166.00
Ask:
182.00
Spread: 16.00 (9.639%)
Market Cap: £104.96m
JZCP Live PriceLast checked at - London Stock Exchange

Intraday Jz Capital Share Chart

US Acquisitions

25 Nov 2014 13:00

RNS Number : 9508X
JZ Capital Partners Ltd
25 November 2014
 



 

 

JZ CAPITAL PARTNERS EXPANDS PORTFOLIO WITH TWO U.S. ACQUISITIONS

25 November 2014

JZ Capital Partners Limited (LSE:JZCP.L or "JZCP"), the London listed private equity fund that invests in high quality US and European microcap companies, has expanded its US vertical portfolio by making two acquisitions alongside Edgewater Funds LP ("Edgewater").

JZCP and Edgewater invested $1.6 million each to acquire Action Products Marketing Corporation and ConShield Technologies Incorporated ("APMCS"), an infrastructure rehabilitation company headquartered in Johnston, Iowa. The company specialises in formulating and selling cementitious manhole and pipe rehabilitation products and provides the associated equipment used for application itself. The acquisition of APMCS is the third for the water infrastructure sub-vertical and the sixth for the water business overall.

JZCP and Edgewater also invested $1.31 million each to acquire PPM Information Solutions, Inc. ("PPMIS"), an anaesthesia billing software and service company. PPMIS operates two business lines, generating revenue from its proprietary billing and practice management software platform used by anaesthesia practices and other billing companies, and by providing outsourced medical billing services to anaesthesia practices. The acquisition of PPMIS is the third for the Bolder Healthcare Solutions vertical.

David Zalaznick, JZCP's Founder and Investment Adviser, commented:"Both acquisitions demonstrate the scope and expansion of our US portfolio and the strength of our investment pipeline. We are confident in the growth prospects of both companies and look forward to assisting them in reaching their full potential.

Both APMCS and PPMIS hold strong positions in their respective sectors and offer considerable opportunities to expand product range to appeal to their customers. We look forward to working with our co-investor Edgewater and the management teams of both companies over the coming years."

 

Ends

 

For further information:

 

Ed Berry / Kit Dunford +44 (0) 20 3727 1143

FTI Consulting

 

David Zalaznick +1 212 572 0800

Jordan/Zalaznick Advisers, Inc.

 

Andrew Maiden +44 (0) 1481 745368

JZ Capital Partners

 

About JZCP

 

JZCP is a London and Channel Islands listed private equity fund which invests in high quality US and European microcap companies. Its objective is to achieve a superior overall return comprised of a current yield and significant capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. ("JZAI") which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI's experts work with the existing management of microcap companies to help build better businesses, create value and deliver strong returns for investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLELFLZFFZFBV
Date   Source Headline
28th Jul 20167:00 amPRNJZCP investment in Oncology Services International
26th Jul 20167:00 amPRNApple leases JZCP property in Brooklyn, New York
21st Jul 20167:00 amPRNNet Asset Value(s)
22nd Jun 20162:01 pmPRN2016 Zero Dividend Preference Shares
20th Jun 20167:00 amPRNInterim Management Statement
17th Jun 20164:15 pmPRNResult of EGM Announcement
17th Jun 20164:06 pmPRNResult of AGM Announcement
27th May 20169:49 amPRNNet Asset Value(s)
24th May 20168:54 amPRNNotice of EGM
23rd May 201611:15 amPRN2016 Zero Dividend Preference Shares
23rd May 20169:08 amPRNNotice of AGM
19th May 201612:39 pmPRNDirector/PDMR Shareholding
19th May 20169:34 amPRNNet Asset Value(s)
12th May 201612:47 pmPRNDividend Declaration
12th May 20167:00 amPRNAnnual Financial Report
21st Apr 20168:00 amPRNNotice of Results
22nd Feb 20169:48 amPRNNet Asset Value(s)
9th Feb 20167:00 amPRNJZCP Completes Sale of Six European Investments
29th Jan 20164:58 pmPRNDisclosure of Home Member State
28th Jan 20164:13 pmPRNAIC Reclassification
28th Jan 20167:00 amPRNNet Asset Value(s)
22nd Dec 20153:33 pmPRNNet Asset Value(s)
21st Dec 20157:00 amPRNInterim Management Statement
15th Dec 201510:06 amPRNHolding(s) in Company
23rd Nov 20157:00 amPRNNet Asset Value(s)
17th Nov 20157:00 amPRNDisposal
10th Nov 20159:36 amPRNNet Asset Value(s)
28th Oct 20157:01 amPRNDividend Declaration
28th Oct 20157:00 amPRNHalf-yearly Report
16th Oct 20158:30 amPRNNotice of Results
5th Oct 20154:37 pmPRNDirector/PDMR Shareholding
29th Sep 20152:15 pmPRNResults of Placing and Open Offer
16th Sep 20157:00 amPRNNet Asset Value(s)
4th Sep 20155:10 pmPRNPublication of Prospectus and Separate ZDP Circular
4th Sep 20158:44 amPRNFurther Information on Proposed Placing and Open Offer
4th Sep 20157:00 amPRNProposed Placing and Open Offer
2nd Sep 20157:00 amPRNFirst Close of JZI Fund III
25th Aug 20159:52 amPRNNet Asset Value(s)
29th Jul 20157:00 amPRNNet Asset Value(s)
22nd Jun 20157:00 amPRNNet Asset Value(s)
21st Jun 201510:58 pmPRNInterim Management Statement
19th Jun 20154:50 pmPRNResult of AGM
19th Jun 20154:50 pmPRNResult of EGM
15th Jun 20157:00 amPRNK2 Co-Investment
12th Jun 20157:00 amPRNNet Asset Value(s)
2nd Jun 20157:00 amPRNNet Asset Value(s)
28th May 20154:35 pmRNSPrice Monitoring Extension
21st May 20159:30 amPRNNotice of EGM
20th May 201510:39 amPRNNotice of AGM and Accounts
19th May 20157:00 amPRNSloan LED Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.